83 related articles for article (PubMed ID: 3300436)
1. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.
Kemp JP; Orgel HA; Grossman J; Reed CE; Tinkelman DG; Webb DR; Ziment I
Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436
[TBL] [Abstract][Full Text] [Related]
2. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol.
Nathan RA; Bodman SF; Storms WW; Mingo TS
Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma.
Nathan RA; Bernstein IL; Bronsky EA; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Pinnas JL; Repsher LH
J Allergy Clin Immunol; 1987 May; 79(5):822-9. PubMed ID: 3571773
[TBL] [Abstract][Full Text] [Related]
4. Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients.
Pinnas JL; Bernstein IL; Bronsky EE; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Nathan RA; Repsher LH; Bhatt BD
J Allergy Clin Immunol; 1987 May; 79(5):768-75. PubMed ID: 3571768
[TBL] [Abstract][Full Text] [Related]
5. Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.
Nathan RA; Bronsky EA; Dockhorn RJ; Kemp JP
Ann Allergy; 1994 Mar; 72(3):209-16. PubMed ID: 8129213
[TBL] [Abstract][Full Text] [Related]
6. Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.
Pinnas JL; Bhatt BD; Campbell SC; Kemp JP; Tinkelman DG
Chest; 1987 Apr; 91(4):533-9. PubMed ID: 3549173
[TBL] [Abstract][Full Text] [Related]
7. Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm.
Messina MS
Adv Ther; 1995; 12(3):157-63. PubMed ID: 10155050
[TBL] [Abstract][Full Text] [Related]
8. Bitolterol mesylate in exercise-induced asthma.
Walker SB; Bierman CW; Pierson WE; Shapiro GG; Furukawa CT; Mingo TS
J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):32-6. PubMed ID: 3944373
[TBL] [Abstract][Full Text] [Related]
9. Long-term study comparing fenoterol and isoproterenol inhalation in asthmatic patients.
Brandon ML
Ann Allergy; 1978 Feb; 40(2):86-93. PubMed ID: 343660
[TBL] [Abstract][Full Text] [Related]
10. Terbutaline sulfate and isoproterenol sulfate (metered dose aerosols) in the treatment of asthma.
Kemp JP; Orgel HA; Meltzer EO; Welch MJ
Ann Allergy; 1983 Oct; 51(4):436-40. PubMed ID: 6354007
[TBL] [Abstract][Full Text] [Related]
11. Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoring.
Kemp JP; Chervinsky P; Orgel HA; Meltzer EO; Noyes JH; Mingo TS
J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):32-43. PubMed ID: 6693665
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bronchodilator responses with bitolterol mesylate solution with the use of two different nebulizer systems in asthma.
Kemp JP; Pinnas JL; Tinkelman DG; Meltzer EO; Campbell SC; Orgel HA; Welch MJ; Mingo TS
J Allergy Clin Immunol; 1986 Mar; 77(3):509-15. PubMed ID: 3950254
[TBL] [Abstract][Full Text] [Related]
13. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
Orgel HA; Kemp JP; Tinkelman DG; Webb DR
J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):55-62. PubMed ID: 3968329
[TBL] [Abstract][Full Text] [Related]
14. Particle-size distribution of bitolterol mesylate solution delivered by four compressed-air nebulizer devices.
Hunke WA; Yu AB
Am J Hosp Pharm; 1987 Jun; 44(6):1392-6. PubMed ID: 3618619
[TBL] [Abstract][Full Text] [Related]
15. Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children.
Rhoades RB; Leifer KN; Bloom FL; Wittig HJ
Am Rev Respir Dis; 1976 Jul; 114(1):79-86. PubMed ID: 7174
[TBL] [Abstract][Full Text] [Related]
16. Double-blind trial of oral carbuterol in bronchial asthma.
Miller J; Wallace D; Grieco MH; Frenkel R; Larsen K
Ann Allergy; 1977 Jul; 39(1):12-7. PubMed ID: 18957
[TBL] [Abstract][Full Text] [Related]
17. A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults.
Nowak R; Emerman C; Hanrahan JP; Parsey MV; Hanania NA; Claus R; Schaefer K; Baumgartner RA;
Am J Emerg Med; 2006 May; 24(3):259-67. PubMed ID: 16635694
[TBL] [Abstract][Full Text] [Related]
18. Bitolterol compared to isoproterenol in advanced chronic obstructive pulmonary disease.
Petty TL; Scoggin CH; Rollins DR; Repsher LH
Chest; 1984 Sep; 86(3):404-8. PubMed ID: 6380974
[TBL] [Abstract][Full Text] [Related]
19. The role of intrinsic efficacy in determining response to a beta2-agonist in acute severe asthma.
Hanania NA; Moore RH; Zimmerman JL; Miller CT; Bag R; Sharafkhaneh A; Dickey BF
Respir Med; 2007 May; 101(5):1007-14. PubMed ID: 17052901
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the bronchodilating action and of the tolerance of fenoterol and isoproterenol aerosols.
Takishima T; Sasaki T; Sasaki H; Sugiyama M; Nakamura M
Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():540-2. PubMed ID: 6352316
[No Abstract] [Full Text] [Related]
[Next] [New Search]
